Abbott India

48
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE358A01014
  • NSEID: ABBOTINDIA
  • BSEID: 500488
INR
27,800.00
245 (0.89%)
BSENSE

Jul 31, 03:51 PM

BSE+NSE Vol: 6.62 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Abbott India Cash flow Statement
Figures in Cr
Standaloned Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Abbott India
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
2079.27
2154.02
-75.00
-3.47%
Adjustment
-149.85
154.2
-303.00
-197.18%
Changes In working Capital
-70.49
-1136.55
1,066.00
93.80%
Cash Flow after changes in Working Capital
1858.93
1171.67
687.00
58.66%
Cash Flow from Operating Activities
1319.24
588.8
731.00
124.06%
Cash Flow from Investing Activities
-371.38
-489.9
118.00
24.19%
Cash Flow from Financing Activities
-1066.12
-95.41
-971.00
-1017.41%
Net Cash Inflow / Outflow
-118.26
3.49
-121.00
-3488.54%
Opening Cash & Cash Equivalents
560.59
127.96
433.00
338.10%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
442.33
131.45
311.00
236.50%
Cash Flow - Snapshot (Standalone) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 30.38% vs -16.57% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
1,319.24
1,011.84
30.38%